Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
amgen
biotech
bristol-myers squibb
drugs
fda
ifm therapeutics
investing
larotrectinib
loxo oncology
new england journal of medicine
What
drug
4
×
cancer
roundup
bio
new
pricing
advanced
advantages
ahead
ambien
american
annual
approved
arrival
asco
attendees
attention
award
bar
biotech
brings
camp’s
cash
chicago
city
clinical
combinations
community’s
data
days
death
decades
deeper
dems
dna
expanding
expect
fda
fingerprint
focus
Language
unset
Current search:
roche
×
drug
×
" seattle top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More